Year None202420232022202120202019201820172016 Date Latest Press Release November 6, 2017 Eiger BioPharmaceuticals to Participate in Upcoming Investor Conferences October 31, 2017 Eiger BioPharmaceuticals Announces Closing of Public Offering of Common Stock and Exercise In Full of Underwriter's Option to Purchase Additional Shares October 27, 2017 Eiger BioPharmaceuticals Announces Pricing of Public Offering of Common Stock October 26, 2017 Eiger BioPharmaceuticals Announces Proposed Public Offering of Common Stock October 23, 2017 Eiger Announces Positive Phase 2 Interim 24-Week Data with Pegylated Interferon Lambda in Hepatitis Delta Virus (HDV) Infection at the American Association for the Study of Liver Diseases (AASLD) Meeting October 2, 2017 Eiger Announces Abstracts and Presentations at the American Association for the Study of Liver Diseases (AASLD) Meeting September 18, 2017 Eiger Announces Appointment of Biopharmaceutical Industry Veteran Evan Loh, MD to its Board of Directors September 5, 2017 Eiger Announces FDA Orphan Drug Designation Granted for Pegylated Interferon Lambda in Hepatitis Delta Virus Infection August 30, 2017 Eiger BioPharmaceuticals to Present at Two Upcoming Investor Conferences August 14, 2017 Eiger BioPharmaceuticals Reports Second Quarter 2017 Financial Results Pagination First page « first Previous page ‹ previous … Page 15 Page 16 Page 17 Page 18 Current page 19 Page 20 Page 21 Page 22 Page 23 … Next page next › Last page last »